Resurrect Bio

Summary active Updated May 14, 2026

This profile is AI-generated. If you spot an error, please help us fix it by sharing a URL to the correct information.

Location London, United Kingdom
Founded 2021
Latest Stage Series A
Total Raised $12.4M
Website https://www.resurrect.bio/
Sector
biotech agtech ai crop-science gene-editing deep-tech

Founders

Cian Duggan CEO

About

Resurrect Bio is a London-based agricultural biotech company (spinout from The Sainsbury Laboratory) developing AI-driven gene-editing technology that “resurrects” dormant disease resistance in crops 12. The platform comprises FloraFold (AI discovery engine for plant-pathogen protein interactions), a high-throughput validation system, and a resurrection platform that reactivates cryptic resistance traits in elite germplasm 12. The Series A had an initial close of $8.1M (February 17, 2026) and a final close of $10.3M (announced May 13, 2026, oversubscribed), bringing total funding to $12.4M since the 2023 seed round; led by Corteva Agriscience (via Catalyst platform) with participation from Calculus Capital, Pymwymic, UKI2S, SynBioVen, and AgFunder 123.

Funding History

Date Round Amount Lead Co-investors
2026-05-13 Series A (final close) $10.3M Corteva Agriscience Calculus Capital, Pymwymic, UKI2S, SynBioVen, AgFunder 12
2026-02-17 Series A (initial close) $8.1M Corteva Agriscience Calculus Capital, Pymwymic, UKI2S, SynBioVen, AgFunder 3

What Investors Say

No independently sourced investor quotes found at this time.

What Founders Say

Dr. Cian Duggan, CEO, said the oversubscribed raise reflects “growing conviction” in the company’s AI-driven approach to resurrecting dormant disease-resistance traits in crops. 1

Sources

  1. AgTechNavigator, “Resurrect Bio closes $10.3M Series A as investors back AI-led crop immunity,” May 13, 2026. Accessed May 2026. https://www.agtechnavigator.com/Article/2026/05/13/resurrect-bio-closes-103m-series-a-as-investors-back-ai-led-crop-immunity/↩↩↩↩↩

  2. AgFunder News, “Resurrect Bio expands Series A to $10.3m to scale tech helping plants to defend themselves,” May 2026. Accessed May 2026. https://agfundernews.com/resurrect-bio-expands-series-a-to-10-3m-to-scale-tech-helping-plants-to-defend-themselves↩↩↩↩

  3. Resurrect Bio, “Resurrect Bio Closes Initial $8M Series A,” February 17, 2026. Accessed May 2026. https://www.resurrect.bio/news/resurrect-bio-raises-over-8m-series-a-to-transform-plant-immunity↩↩